Halozyme Therapeutics | HALO - Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Halozyme Therapeutics

Halozyme Therapeutics reported $1.7B in Assets for its fiscal quarter ending in March of 2023.


Assets Change
Acadia Pharmaceuticals ACAD:US USD 655.3M 67.49M
Agios Pharmaceuticals AGIO:US USD 1.15B 87.42M
Alnylam Pharmaceuticals ALNY:US USD 3.39B 154.42M
Amarin AMRN:US USD 860.19M 25.99M
Amgen AMGN:US USD 88.72B 23.6B
Baxter International BAX:US USD 28.29B 4M
Cara Therapeutics CARA:US USD 153.28M 28.96M
Cytokinetics CYTK:US USD 889.82M 124.96M
DBV Technologies DBVT:US USD 232.93M 13.59M
Eli Lilly LLY:US USD 53.16B 3.67B
Esperion Therapeutics ESPR:US USD 251.82M 3.88M
Halozyme Therapeutics HALO:US USD 1.7B 142.06M
Immunogen IMGN:US USD 288.34M 60.59M
Intercept Pharmaceuticals ICPT:US USD 504.08M 49.63M
Intra Cellular Therapies ITCI:US USD 722.16M 32.62M
Intrexon XON:US USD 241.55M 25.57M
Ionis Pharmaceuticals IONS:US USD 2.89B 351.34M
MannKind MNKD:US USD 298.14M 2.86M
Minerva Neurosciences NERV:US USD 51.6M 3.49M
Nektar Therapeutics NKTR:US USD 561.74M 148.86M
Peregrine Pharmaceuticals PPHM:US USD 450.43M 8.58M
Rigel Pharmaceuticals RIGL:US USD 123.61M 10.67M
United Therapeutics UTHR:US USD 6.35B 301.5M
Vanda Pharmaceuticals VNDA:US USD 644.53M 10.28M